Butoprozine

This classification denotes an antiarrhythmic agent with the molecular formula C28H38N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9XWF3530OG chemically known as methanone, (4-(3-(dibutylamino)-propoxy)phenyl)(2-ethyl-3-indolizinyl)-, but more commonly known as butoprozine, which bears US NIH Compound Identifier 71959. European Medicines Agency schedules Butoprozine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06033MIG. The term BUTOPROZINE is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule butoprozine under HS 29339990 and SITC 51577. As of Q4 2014, BUTOPROZINE remains US FDA's Preferred Term for this commodity. Butoprozine bears US NLM identifiers UMLS ID C0054266 and NCI Concept Code C79924. SMILES: CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C2=C(C=C3N2C=CC=C3)CC.